Straits Times Index
3,303.64 -10.41 (-0.31%) Nikkei
39,135.91 +66.23 (+0.17%) Hang Seng
19,235.43 -400.79 (-2.04%) FTSE 100
8,424.20 +3.94 (+0.05%) Bitcoin USD
71,315.89 +4,638.79 (+6.96%) CMC Crypto 200
1,516.74 +162.33 (+12.01%)
Hamilton Thorne Ltd. (HTLZF)
| Previous close | 1.0200 |
| Open | 1.0000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 1.0000 - 1.0000 |
| 52-week range | 0.8030 - 1.2100 |
| Volume | |
| Avg. volume | 5,385 |
| Market cap | 156.957M |
| Beta (5Y monthly) | 0.28 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter Ended March 31, 2024, and Confirms Annual Guidance
Revenue of $19.4 million and Adjusted EBITDA of $3.5 for the quarterBEVERLY, Mass. and TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software, and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the quarter ended March 31, 2024. Financial Highlights 1st quarter sales increased 16% to $19.4 million;
- GlobeNewswire
Hamilton Thorne to Announce Q1 2024 Financial Results and Hold Conference Call on May 14, 2024
BEVERLY, Mass. and TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three months ended March 31, 2024 before market open on Tuesday, May 14, 2024. The press release, with accompanying financial information, will be poste
- GlobeNewswire
Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2023
Revenue of $67.2 million for the year and $18.4 million for the 4th quarter; Adj. EBITDA of $11.5 million for the year and $3.7 million for the quarterBEVERLY, Mass. and TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the fourth quarter an
